[Influenza vaccination in children: Inactivated vaccines or live attenuated vaccines?].

Arch Pediatr

Laboratoire de virologie, CHU de Caen, avenue Clemenceau, 14033 Caen, France; Groupe de recherche sur l'adaptation microbienne (GRAM2), Normandie université, UNICAEN, UNIROUEN, 14000 Caen, France.

Published: March 2017

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arcped.2016.12.008DOI Listing

Publication Analysis

Top Keywords

[influenza vaccination
4
vaccination children
4
children inactivated
4
inactivated vaccines
4
vaccines live
4
live attenuated
4
attenuated vaccines?]
4
[influenza
1
children
1
inactivated
1

Similar Publications

Background: Infections by and influenza viruses are vaccine-preventable diseases causing great morbidity and mortality. We evaluated pneumococcal and influenza vaccination practices during pre-international travel health consultations.

Methods: We evaluated data on pretravel visits over a 10-year period (1 July 2012 through 31 June 2022) from 31 sites in Global TravEpiNet (GTEN), a consortium of US healthcare facilities providing pretravel health consultations.

View Article and Find Full Text PDF

Influenza surveillance is important for monitoring influenza virus circulation and disease burden to inform influenza prevention and control measures. The aim of this study was to describe the epidemiology and to estimate the incidence of influenza in two communities in West Java, Indonesia, before and after the 2009 H1N1 pandemic. A population-based surveillance study in the community health care setting was conducted to estimate the annual incidence of influenza.

View Article and Find Full Text PDF

Rapid and sensitive detection of virus-related antigens and antibodies is crucial for controlling sudden seasonal epidemics and monitoring neutralizing antibody levels after vaccination. However, conventional detection methods still face challenges related to compatibility with rapid, highly sensitive, and compact detection apparatus. In this work, we developed a Si nanowire (SiNW)-based field-effect biosensor by precisely controlling the process conditions to achieve the required electrical properties via complementary metal-oxide-semiconductor (CMOS)-compatible nanofabrication processes.

View Article and Find Full Text PDF

Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection.

Nat Microbiol

January 2025

State key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

Generating effective live vaccines from intact viruses remains challenging owing to considerations of safety and immunogenicity. Approaches that can be applied in a systematic manner are needed. Here we created a library of live attenuated influenza vaccines by using diverse cellular E3 ubiquitin ligases to generate proteolysis-targeting (PROTAR) influenza A viruses.

View Article and Find Full Text PDF

PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins.

Nat Chem Biol

January 2025

State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

Manipulating viral protein stability using the cellular ubiquitin-proteasome system (UPS) represents a promising approach for developing live-attenuated vaccines. The first-generation proteolysis-targeting (PROTAR) vaccine had limitations, as it incorporates proteasome-targeting degrons (PTDs) at only the terminal ends of viral proteins, potentially restricting its broad application. Here we developed the next-generation PROTAR vaccine approach, referred to as PROTAR 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!